Abrenica, Kianna O.

HRN: 22-65-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2023
AMPICILLIN 1GM (VIAL)
05/03/2023
05/10/2023
IV
155mg
Q12
Sepsis
Waiting Final Action 
05/03/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/03/2023
05/10/2023
IV
46mg
Q24
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: